Series B funding round for Ashvattha Therapeutics raising $50M in January 2025
Series B funding round for Ashvattha Therapeutics raising $50M in January 2025
| Investor | Firm Type | Partner |
|---|
Tribe CapitalLEAD | Venture Capital | — |
Natural CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Gokul Rajaram | |
| Angel | Stuart Peterson | |
| Angel | Vasudev Bailey | |
| Angel | Cory Levy | |
| Angel | Michael Stoppelman | |
| Angel | Liu Jiang |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$126M
Top Valuation
-
Ashvattha Therapeutics raised $50M in a Series B round.
The round was announced on 01/01/25.
The round was led by Tribe Capital, Jay Zaveri.